---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-059126"
form_type: "8-K"
ticker: "BNBX"
cik: "0000744452"
company_name: "BNB PLUS CORP."
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T05:15:11.501016+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Applied DNA Q2 FY2023 revenue falls 28% to $4.4M; identifies mRNA acquisition target

## Summary
- Total revenues $4.4M, down from $6.1M YoY; COVID-19 testing revenue declined $1.5M.
- Operating loss $2.7M vs $2.2M prior year; Adjusted EBITDA -$2.1M vs -$1.6M.
- Cash $12.3M as of March 31, 2023, down from $15.2M in December 2022.
- Identified mRNA value chain acquisition target; expects closing by June 30, 2023.
- Submitted PGx assay validation to NYSDOH; approval anticipated in coming months.

## SEC filing metadata
- accession: 0001104659-23-059126
- form_type: 8-K
- ticker: BNBX
- cik: 0000744452
- company_name: BNB PLUS CORP.
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744452/000110465923059126/0001104659-23-059126-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744452/000110465923059126/tm2315498d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-059126
- JSON: https://secwatch.observer/filing/0001104659-23-059126.json
- Plain text: https://secwatch.observer/filing/0001104659-23-059126.txt

## Key facts
- Earnings Releases
  BNB PLUS CORP. reported second quarter of fiscal 2023 ended March 31, 2023 results: revenue $4.4 million.
  - Period: second quarter of fiscal 2023 ended March 31, 2023
  - Revenue: $4.4 million
  - Result: reported results
  source text: Total revenues were $4.4 million for the three-month period ended March 31, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/744452/000110465923059126/0001104659-23-059126-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.